latest update:
[RxAtlas]

drug summary · 3 NDC codes

Dupixent 200 mg/1.14mL

Dupilumab

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status BLA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 18117NDC codes 3application BLA761055RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic nameDupilumab
active ingredientsDUPILUMAB
dosage formINJECTION, SOLUTION
routeSUBCUTANEOUS
strength200 mg/1.14mL
marketing statusBLA
DEA schedulenot reported
application numberBLA761055
ATC codenot reported
RxCUInot reported
manufacturerSanofi-Aventis U.S. LLC
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classAntibodies; Antibodies, Monoclonal [CS]; Interleukin 4 Receptor alpha Antagonists [MoA]; Interleukin-4 Receptor alpha Antagonist [EPC]; Monoclonal [CS]

NDC codes

3 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
00024591801—
00024591802—
0024-5918—

Other Dupilumab products

One other product in the current release publishes the same generic name. Strength, dosage form, and labeler are what distinguish them.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.